Compartilhar
Informação da revista
Os mais citados
32
ABO blood group association and COVID-19. COVID-19 susceptibility and severity: a reviewSapha Shibeeb, Aisha Khan
Hematol Transfus Cell Ther. 2022;44:70-5
32
Open access
20
Sickle cell disease related mortality in Brazil, 2000–2018Augusto Hasiak Santo
Hematol Transfus Cell Ther. 2022;44:177-85
20
Open access
17
Bibliometric analysis of global sickle cell disease research from 1997 to 2017Henshaw Uchechi Okoroiwu, Francisco López-Muñoz, F. Javier Povedano-Montero
Hematol Transfus Cell Ther. 2022;44:186-96
17
Open access
14
Oral manifestations of leukemia as part of early diagnosisReyna Aguilar Quispe, Elizabeth Marques Aguiar, Claudia Teresa de Oliveira, Ana Cristina Xavier Neves, Paulo Sérgio da Silva Santos
Hematol Transfus Cell Ther. 2022;44:392-401
14
Open access
14
Role of preoperative erythropoietin in the optimization of preoperative anemia among surgical patients — A systematic review and meta-analysisSheikh Muhammad Ebad Ali, Muhammad Hassan Hafeez, Omar Nisar, Sarosh Fatima, Humaira Ghous, Mahwish Rehman
Hematol Transfus Cell Ther. 2022;44:76-84
14
Open access
13
COVID-19 pandemic and blood transfusion services: The impact, response and preparedness experience of a tertiary care blood center in southern Karnataka, IndiaDhivya Kandasamy, Shamee Shastry, Deepika Chenna, Ganesh Mohan
Hematol Transfus Cell Ther. 2022;44:17-25
13
Open access
13
Hematological changes in SARS-COV-2 positive patientsMafalda Urbano, Elísio Costa, Catarina Geraldes
Hematol Transfus Cell Ther. 2022;44:218-24
13
Open access
13
Can SARS-CoV-2 induce hematologic malignancies in predisposed individuals? A case series and review of the literatureBruno Almeida Costa, Kaiza Vilarinho da Luz, Sarah Emanuelle Viana Campos, Germison Silva Lopes, João Paulo de Vasconcelos Leitão, Fernando Barroso Duarte
Hematol Transfus Cell Ther. 2022;44:26-31
13
Open access
10
HFE hemochromatosis: an overview about therapeutic recommendationsRodolfo D. Cancado, Aline Morgan Alvarenga, Paulo Caleb JL Santos
Hematol Transfus Cell Ther. 2022;44:95-9
10
Open access
10
Maternal and perinatal outcomes in pregnant women with sickle cell disease: an updateViviane Teixeira de Sousa, Samir K. Ballas, Júlia Mota Leite, Maria Cristina Albe Olivato, Rodolfo D. Cancado
Hematol Transfus Cell Ther. 2022;44:369-73
10
Open access
Publicar em
Hematology, Transfusion and Cell Therapy
A revista pertence ao Committee on Publication Ethics (COPE) www.publicationethics.org e adere aos seus princípios e procedimentos.